Cargando…
A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes
INTRODUCTION: Adverse events and complications limit the long-term use of current antidiabetic treatment options for patients with type 2 diabetes mellitus (T2DM), particularly for older adults who are often receiving therapy for other comorbid conditions. The aim of this study was to evaluate the b...
Autores principales: | Bron, Morgan, Wilson, Craig, Fleck, Penny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269655/ https://www.ncbi.nlm.nih.gov/pubmed/25424968 http://dx.doi.org/10.1007/s13300-014-0088-5 |
Ejemplares similares
-
Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
por: Ruan, Xu Cong, et al.
Publicado: (2019) -
Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2010) -
Glycemic Control and Hypoglycemia in Veterans Health Administration Patients Converted from Glyburide to Glipizide
por: Skoff, Rachel A., et al.
Publicado: (2011) -
Different levels of hypoglycemia in patients with type 2 diabetes, their achieved mean HbA1c vs. all-cause and cardiovascular mortality
por: Ooi, Seng-Wei, et al.
Publicado: (2023) -
HbA(1c) and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes and Aging Study
por: Lipska, Kasia J., et al.
Publicado: (2013)